Abbott Laboratories SEC filings ABT
Abbott Laboratories has 1,001 filings in SEC EDGAR's recent list, going back to Jul 12, 2018. Its latest annual report, Form ARS, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 11-K | Employee savings plan report | Jun 18, 2026 | Dec 31, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 27, 2026 | — |
| 11-K | Employee savings plan report | Jun 20, 2025 | Dec 31, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2025 | — |
| 11-K | Employee savings plan report | Jun 25, 2024 | Dec 31, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2024 | — |
| 11-K | Employee savings plan report | Jun 23, 2023 | Dec 31, 2022 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2023 | — |
| PX14A6G | Filing | Apr 10, 2023 | — |
| PX14A6G | Filing | Apr 5, 2023 | — |
| 11-K | Employee savings plan report | Jun 27, 2022 | Dec 31, 2021 |
| SD | Specialized disclosure (conflict minerals) | May 27, 2022 | — |
| PX14A6G | Filing | Mar 25, 2022 | — |
| PX14A6G | Filing | Mar 24, 2022 | — |
| PX14A6G | Filing | Mar 21, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2022 | — |
| CORRESP | Letter to the SEC | Feb 4, 2022 | — |
| CORRESP | Letter to the SEC | Jan 31, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2021 | — |
| CORRESP | Letter to the SEC | Oct 5, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2021 | — |
| 11-K | Employee savings plan report | Jun 28, 2021 | Dec 31, 2020 |
| SD | Specialized disclosure (conflict minerals) | May 28, 2021 | — |
| PX14A6G | Filing | Mar 17, 2021 | — |
| 11-K | Employee savings plan report | Jun 26, 2020 | Dec 31, 2019 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2020 | — |
| PX14A6G | Filing | Mar 24, 2020 | — |
| 11-K | Employee savings plan report | Jun 27, 2019 | Dec 31, 2018 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2019 | — |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- IL
- Headquarters
- Abbott Park, IL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1800
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Novo Nordisk A S NVO
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.